日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Automated patch clamp analysis of heterologously expressed Kir6.2/SUR1 and Kir6.1/SUR2B K(ATP) currents.

异源表达的 Kir6.2/SUR1 和 Kir6.1/SUR2B K(ATP) 电流的自动膜片钳分析

Li Kangjun, Janve Vaishali Satpute, Denton Jerod S

Predicting Intraocular Collamer Lens Vault in Myopic Patients With Shallow Anterior Chamber Using FedEYE Platform and ChatGPT

利用 FedEYE 平台和 ChatGPT 预测浅前房近视患者的眼内胶原蛋白晶状体拱高

Su, Zhanyu; Wang, Zhaoxiang; Wang, Shanshan; Ni, Meng; Hu, Jinwei; Wang, Ruiwen; Yang, Jie; Bai, Yunxia; Xu, Yonghong; Di, Shuli; Xu, Yaqian; Wang, Zheng; Chen, Zhuoyue; Ortega-Usobiaga, Julio; Wang, Ming X; Jiang, Xinlong; Chen, Yiqiang; Dai, Weiwei; Chen, Jiansu; Li, Kangjun

Characterization of four structurally diverse inhibitors of SUR2-containing K(ATP) channels

对四种结构各异的含SUR2的K(ATP)通道抑制剂进行表征

Li, Kangjun; Satpute Janve, Vaishali; Denton, Jerod

Discovery and Characterization of VU0542270, the First Selective Inhibitor of Vascular Kir6.1/SUR2B K(ATP) Channels

VU0542270 的发现与表征:首个血管 Kir6.1/SUR2B K(ATP) 通道选择性抑制剂

Li, Kangjun; McClenahan, Samantha J; Han, Changho; Bungard, Joseph D; Rathnayake, Upendra; Boutaud, Olivier; Bauer, Joshua A; Days, Emily L; Lindsley, Craig W; Shelton, Elaine L; Denton, Jerod S

Synthesis and SAR of a novel Kir6.2/SUR1 channel opener scaffold identified by HTS

通过高通量筛选鉴定出一种新型 Kir6.2/SUR1 通道开放剂骨架,并对其合成和构效关系进行了研究。

Dodd, Cayden J; Chronister, Keagan S; Rathnayake, Upendra; Parr, Lauren C; Li, Kangjun; Chang, Sichen; Mi, Dehui; Days, Emily L; Bauer, Joshua A; Cho, Hyekyung P; Boutaud, Olivier; Denton, Jerod S; Lindsley, Craig W; Han, Changho

Providing a New Aniline Bioisostere through the Photochemical Production of 1-Aminonorbornanes

通过光化学法合成1-氨基降冰片烷获得新的苯胺生物等排体

Staveness, Daryl; Sodano, Taylor M; Li, Kangjun; Burnham, Elizabeth A; Jackson, Klarissa D; Stephenson, Corey R J